Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients

被引:42
作者
Ferraro, B
Galli, F
Frei, B
Kingdon, E
Canestrari, F
Rice-Evans, C
Buoncristiani, U
Davenport, A
Moore, KP
机构
[1] UCL Royal Free & Univ Coll Med Sch, Ctr Hepatol, Dept Med, Univ Coll London, London NW3 2PF, England
[2] UCL Royal Free & Univ Coll Med Sch, Ctr Nephrol, Dept Med, Univ Coll London, London NW3 2PF, England
[3] Univ Urbino, G Fornaini Inst Biol Chem, I-61029 Urbino, Italy
[4] Oregon State Univ, Linus Pauling Inst, Portland, OR USA
[5] Guys Hosp, Wolfson Ctr Age Related Dis, Guys Kings & St Thomas Sch Biomed Sci, London SE1 9RT, England
[6] R Silvestrini Reg Hosp, Nephrol & Dialysis Unit, Perugia, Italy
关键词
F(2)-isoprostanes; chronic renal failure; SIN-1; lipid peroxidation; dialysis;
D O I
10.1046/j.1523-1755.2003.00008.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background. The relationship between end-stage renal disease (ESRD), hemodialysis, and oxidative stress is controversial. To determine whether ESRD causes oxidative stress, we measured basal levels of plasma F(2)-isoprostanes as a marker of lipid peroxidation in vivo, and peroxynitrite-stimulated formation of F(2)-isoprostanes, as a marker of the oxidizibility of plasma lipids in vitro, before and after routine hemodialysis. Methods. Total plasma F(2)-isoprostanes were measured by gas chromatography-mass spectrometry (GC-MS) before and after the oxidation of plasma lipids with the peroxynitrite-generating compound, 3-morpholino-sydnonimine (SIN-1), in 23 patients with ESRD patients undergoing regular hemodialysis, and 14 controls. Plasma vitamin E concentrations were measured by high-performance liquid chromatography (HPLC). Results. There was no difference in basal plasma concentrations of F(2)-isoprostanes in the ESRD group prior to hemodialysis, 246+/-20 pg/mL, compared to controls, 252+/-28 pg/mL, or immediately on completion of hemodialysis, 236+/-14 pg/mL. Incubation of control plasma with SIN-1 caused the formation of F(2)-isoprostanes with plasma concentrations increasing to 987+/-54 pg/mL at 6 hours. The formation of F(2)-isoprostanes stimulated by SIN-1 was markedly enhanced in the plasma obtained from patients undergoing hemodialysis at 1861+/-174 pg/mL, P<0.001, and SIN-1-induced formation of F(2)-isoprostanes was further increased in plasma obtained immediately after hemodialysis at 2437+/-168 pg/mL, P<0.001. Incubation of plasma with SIN-1 resulted in the net consumption of vitamin E. Conclusion. Although basal plasma F(2)-isoprostanes were similar in patients with ESRD compared with controls, the presence of oxidative stress in patients with ESRD was unmasked when the plasma was stressed by peroxynitrite generated from SIN-1, and this was enhanced further by hemodialysis.
引用
收藏
页码:2207 / 2213
页数:7
相关论文
共 36 条
[1]
Bauer V, 1999, GEN PHYSIOL BIOPHYS, V18, P7
[2]
Oxidation of LDL by myeloperoxidase and reactive nitrogen species - Reaction pathways and antioxidant protection [J].
Carr, AC ;
McCall, MR ;
Frei, B .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (07) :1716-1723
[3]
Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients [J].
Clermont, G ;
Lecour, S ;
Lahet, JJ ;
Siohan, P ;
Vergely, C ;
Chevet, D ;
Rifle, G ;
Rochette, L .
CARDIOVASCULAR RESEARCH, 2000, 47 (03) :618-623
[4]
Cracowski JL, 2000, PRESSE MED, V29, P604
[5]
DASGUPTA A, 1990, CLIN PHYSIOL BIOCH, V8, P238
[6]
Oxidant stress in nephrotic syndrome:: comparison of F2-isprostanes and plasma antioxidant potential [J].
Dogra, G ;
Ward, N ;
Croft, KD ;
Mori, TA ;
Barrett, PHR ;
Herrmann, SE ;
Irish, AB ;
Watts, GF .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (08) :1626-1630
[7]
ASCORBATE IS AN OUTSTANDING ANTIOXIDANT IN HUMAN-BLOOD PLASMA [J].
FREI, B ;
ENGLAND, L ;
AMES, BN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (16) :6377-6381
[8]
Galli F, 1999, Contrib Nephrol, V127, P156
[9]
Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases [J].
Greco, A ;
Minghetti, L ;
Levi, G .
NEUROCHEMICAL RESEARCH, 2000, 25 (9-10) :1357-1364
[10]
HALLIWELL B, 1993, HAEMOSTASIS, V23, P118